But the biotech’s newest update has failed to garner the same investor enthusiasm, with the company’s stock nearly halved following the data drop.
A bill that would ban cellphone use from "bell to bell" was advanced out of committee Tuesday to a full vote before the state Senate.
Chile has passed a bill outlawing the use of mobile phones and other smart devices during classes at elementary and middle ...
Landmark results could pave the way for miv-cel to become the first FDA-approved CAR T-cell therapy for autoimmune disease; Company on track to submit BLA for stiff person syndrome in 1H 2026 Miv-cel ...
Three cheers for automotive minutiae! Earlier this week we asked you to indulge in some automotive minutiae and share with ...
ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of ...
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...
Tens of millions of AT&T customers have just over a week to claim their share of a $177 million settlement stemming from two ...
A December 2024 order prompted by class actions required the US Bureau of Prisons to provide proper safeguards to prevent ...
We are delighted that isupartob sodium has been recognized as a first-in-class therapy through the award of its International Nonproprietary Name (INN), which includes a new and distinctive suffix.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback